Lazzaro Spallanzani Roman Hospital, which specializes in infectious diseases, began testing a vaccine against the coronavirus on humans today. The hospital management reported that the first volunteer had already received the first dose of vaccine.
3,000 people registered as volunteers for the test, 90 were selected by the doctors. You will receive 700 euros for your participation. The vaccine was developed in Italy and was created thanks to an agreement that the government signed with the Spallanzani Institute.
Production only after tests
The vaccine was developed and patented by the biotechnology company ReiThera, based in Castelromano near Rome, together with the Munich company Leukocare and Univercells (Brussels). Production will only start after the tests.
The preventive vaccine is said to boost the production of antibodies and the activity of immune cells. The three pharmaceutical companies decided to join forces to accelerate the development of a vaccine. The challenge is to produce millions of cans in a rush.
